Expression and phosphorylation status of retinoblastoma protein in adult T-cell leukemia/lymphoma

Leukemia Research

Volumn 24, Issue 4, 2000, Pages 299-305

  Nakayama, Katsushi ^a   Yamada, Yasuaki ^a   Koji, Takehiko ^a   Hayashi, Tomayoshi ^b   Tomonaga, Masao ^c   Kamihira, Shimeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

Author keywords

Adult T cell leukemia lymphoma; Cell cycle; Immunochemistry; Retinoblastoma protein; Western blotting

Indexed keywords

RETINOBLASTOMA PROTEIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL CYCLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPHOMA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; T CELL LEUKEMIA; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; MALE; MIDDLE AGED; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN;

EID: 0034001611     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(99)00186-1     Document Type: Article

References (33)

1. Shimoyama M, Ota K, Kikuci M, Yunoki K, Konda S, Takatsuki K, Ichimaru M, Tominaga S, Tsugane S, Minato K, Tobinai K, Oyama A, Hisano S, Matsumoto M, Takiguchi T, Yamaguchi K, Kinoshita K, Tajima K, Suemasu K. [For the Lymphoma Study Group (1981-1983)], Major prognostic factors of adult patients with advanced T cell lymphoma/leukemia, J Clin Oncol 1988;6:1088.
2. Murphree A.L., Benedict W.F. Retinoblastoma: clues to human oncogenesis. Science. 223:1984;1028.
3. Lee W.H., Bookstein R., Hong F., Young L., Shew J., Lee E.Y.H.P. Human retinooblastoma susceptibility gene: cloning, identification, and sequence. Science. 235:1987;1394.
4. Xu H.J., Hu S.X., Hashimoto T., Takahashi R., Benedict W.F. The retinoblastoma susceptibility gene product: a characteristic pattern in normal cells and abnormal expression in malignant cells. Oncogene. 4:1989;807.
5. Goodrich D., Lee W.H. Molecular characterization of the retinoblastoma susceptibility gene. Biochim. Biophys. Acta. 1155:1993;31.
6. McFall R., Sery T., Makadon M. Characterization of a new continuous cell line derived from a human retinoblastoma. Cancer Res. 37:1977;1003.
7. Harbour J., Lai S., Whang P., Gazdar A., Minna J., Kaye F. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science. 241:1988;353.
8. Cairns P., Proctor A., Knowles M. Loss of heterozygosity at the RB locus is frequent and correlates with muscle inavation in bladder carcinoma. Oncogene. 6:1991;2305.
9. Jamal R., Gale R.E., Thomas N.S.B., Wheatley K., Lynch D.C. The retinoblastoma gene (rb1) in acute myeloid leukaemia: analysis of gene rearrangements, protein expression and comparison of disease outcome. Br. J. Haematol. 94:1996;342.
10. Kornblau S.M., Chen N., del Giglio A., O'Brien S., Deisseroth A.B. Retinoblastoma protein expression is frequently altered in chronic lymphocytic leukemia. Cancer Res. 54:1994;242.
11. Towatari M., Adachi K., Kato H., Saito H. Absence of the human retinoblastoma gene product in the megakaryoblastic crisis of chronic myelogenous leukemia. Blood. 78:1991;2178.
12. Weide R., Tiemann M., Pfluger K. et al. Altered expression of the retinoblastoma gene product in human high-grade non-Hodgkin's lymphomas. Leukemia. 12:1994;97.
13. INK4B, p53, and Rb genes in primary lymphoid malignancies. Blood. 87:1996;4949.
14. Hatta Y., Yamada Y., Tomonaga M., Koeffler H.P. Extensive analysis of the retinoblastoma gene in adult T cell leukemia/lymphoma (ATL). Leukemia. 11:1997;984.
15. Yamada Y., Fujita M., Suzuki H. et al. Established IL-2-dependent double-negative (CD4- CD8-) TCRap/CD3+ ATL cells: induction of CD4 expression. Br. J. Haematol. 88:1994;234.
16. Yamada Y., Nagata Y., Kamihira S. et al. IL-2 dependent ATL cell lines with phenotypes differing from the original leukemia cells. Leuk. Res. 7:1991;619.
17. Shimoyama M, Members of the Lymphoma Study Group. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia/lymphoma, Br J Haematol 1991;79:428.
18. Lee W.H., Shew J.Y., Hong F.D. et al. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature. 329:1987;642.
19. Shew J.Y., Lin B.T., Chen P.L., Tseng B.Y., Yang F.T., Lee W.H. Terminal truncation of the retinoblastoma gene product leads to functional inactivation. Proc. Natl. Acad. Sci. USA. 87:1990;6.
20. Bookstein R., Lee E.Y.H.P., To H. et al. Human retinoblastoma susceptibility gene: genomic organization and analysis of heterozygous intragenic deletion mutants. Proc. Natl. Acad. Sci. USA. 85:1988;2210.
21. Stirzaker C., Millar D.S., Paul C.L. et al. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. Cancer Res. 57:1997;2229.
22. Chen P.L., Scully P., Shew J.Y., Wang J.Y., Lee W.H. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell. 58:1989;1193.
23. DeCaprio J.A., Ludlow J.W., Lynch D. et al. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell. 58:1989;1085.
24. Kornblau S.M., Xu H.J., del Giglio A. et al. Clinical implications of decreased retinoblastoma protein expression in acute myelogenous leukemia. Cancer Res. 52:1992;4587.
25. Furukawa Y., DeCaprio J.A., Freedmann A. et al. Expression and state of phosphorylation of the retinoblastoma susceptibility gene product in cycling and noncycling human hematopoietic cells. Proc. Natl. Acad. Sci. USA. 87:1990;2770.
26. Tsai T., Davalath S., Rankin C., Radich J.P., Head D., Appelbaum F.R., Bolt D.H. Tumor suppressor gene alteration in adult acute lymphoblastic leukemia (AL,L). Analysis of retinoblastoma (Rb) and p53 gene expression in lymphoblasts of patients with de novo, relapsed, or refractory ALL treated in Southwest Oncology Group studies. Leukemia. 10:1996;1901.
27. Zhang X., Xu H.J., Murakami Y. et al. Deletions of chromosome 13q mutations in retinoblastoma 1 and retinoblastoma protein state in human hepatocellular carcinomas. Cancer Res. 54:1994;4177.
28. Martinez J.C., Piris M.A., Sanchez-Beato M. et al. Retinoblastoma (Rb) gene product expression in lymphomas: correlation with Ki67 growth fraction. J. Pathol. 169:1993;405.
29. Martinez J.C., Piris M.A., Sanchez-Beato M. et al. Retinoblastoma (Rb) gene product expression in lymphomas: correlation with Ki67 growth fraction. J. Pathol. 169:1993;405.
30. Grossman H.B., Liebert M., Antelo M., Dinney C.P.N., Hu S.X., Palmer J.L., Benedict W.F. p53 and RB expression predict progression in T1 bladder cancer. Clin. Cancer Res. 4:1998;829.
31. Cote R.J., Dunn M.D., Chatterjee S.J. et al. Elevated and absent pRb expression is associated with bladder cancer progression, and has cooperative effects with pS3. Cancer Res. 58:1998;1090.
32. Dunn M.D., Stein J.P., Shi S.R. et al. Retinoblastoma protein in bladder cancer: level of expression correlates with tumor progression. J. Urol. 157:1997;341A.
33. Haas-Kogan D.A., Kogan S.C., Levi D., Dazin P., T'Ang A., Fung Y.-K.T., Israel M.A. Inhibition of apoptosis by the retinoblastoma gene product. EMBO J. 14:1997;461.